|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���������� |
|
��ɫ���� |
| ��������������� | |
|
���� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
��������������Ժ��������о���״
����, ������
���пƼ���ѧͬ��ҽѧԺ����ͬ��ҽԺƤ���� �人 430030
������������Ϊ�����ڵ�һ����Ҫ��ܵ���,���н鵼ϸ��𤸽����Wnt�źŴ���;��������Ҫ���õ�˫�ع���,���������о�����,������������Ƥ���������б�����䷢������չ��Ԥ���������,����ָ������Ϻ���������Ҫ���塣
[2] Huber AH, Nelson WJ, Weis WI. Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell, 1997, 90:871-882.
[3] Hlsken J, Behrens J. The Wnt signalling pathway. J Cell Sci, 2000,113:3545.
[4] Ben-Ze'ev A, Shtutman M, Zhurinsky J. The integration of cell adhesion with gene expression:the role of beta-catenin. Exp Cell Res,2000, 261:75-82.
[5] Kielhorn E, Provost E, Olsen D, et al. Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer, 2003, 103:652-656.
[6] Omholt K, Platz A, Ringborg U, et al. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int J Cancer, 2001,92:839.
[7] Liu T, DeCostanzo AJ, Liu X,et al. G protein signaling from activated rat frizzled-1 to the beta-catenin-Lef-Tcf pathway. Science,2001, 292:1718-1722.
[8] Kageshita T, Hamby CV, Ishihara T, et al. Loss of beta-catenin expression associated with disease progression in malignant melanoma.Br J Dermatol, 2001, 145:210-216.
[9] Maelandsmo GM, Holm R, Nesland JM,et al. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res, 2003, 9:3383-3388.
[10] Demunter A, Libbrecht L, Degreef H, et al. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations. Mod Pathol,2002, 15:454-461.
[11] Zhang XD, Hersey P. Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma:deficient alpha-catenin expression is associated with melanoma progression. Pathology, 1999, 31:239.
[12] Jouneau A, Yu YQ, Pasdar M, et al. Plasticity of cadherin-catenin expression in the melanocyte lineage. Pigment Cell Res, 2000, 13:260-272.
[13] Pollock PM, Hayward N. Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Res, 2002, 12:183-186.
[14] Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesisa look outside the nucleus. Science, 2000, 287:1606-1609.
[15] Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer, 2002, 34:255-268.
[16] Reifenberger J, Knobbe CB, Wolter M, et al. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer, 2002,100:549-556.
[17] Chen D, Xu W, Bales E, et al. SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res, 2003, 63:6626-6634.
[18] Murakami T, Toda S, Fujimoto M, et al. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells:role of LEF-1 in melanoma with increased metastatic potential. Biochem Biophys Res Commun, 2001, 288:8-15.
[19] Katoh M. Structure and expression of Strabismus 1 gene on human chromosome 1 q21-q23. Int J Oncol, 2002, 20:1197-1203.